Aurobindo Pharma | ARBP - Selling And Administration Expenses

Stock Price
1,509.60
Daily Change
-0.05 -0.003%
Monthly
8.91%
Yearly
25.61%
Q2 Forecast
1,455.31

Aurobindo Pharma reported INR12.77B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Cipla INR 13.25B 101.8M Dec/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Hindustan Unilever INR 15.22B 8.89B Dec/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
UPL INR 15.8B 660M Sep/2025